Search Browse Earnings

ARTELO BIOSCIENCES, INC.

Nasdaq:ARTL

Pharmaceutical Preparations·SOLANA BEACH, CA

Overview All Filings Sum Fin Credit Insiders Governance

Overview All Filings Sum Fin Credit Insiders Governance

Summary Financials

Revenue

—

Adj. EBITDA

-$10.1M

FY 2025

Net Income

-$9.8M

FY 2025

EPS (Diluted)

-$18.30

FY 2025

Stock Price

$1.17

+2.6%

2026-03-09

52W Range

$1.05 – $28.60

P/E Ratio

-0.1x

Market Cap

$2.5M

Cash

$600,000

FY 2025

Total Debt

—

Net Cash

$600,000

Enterprise Value

$1.9M

Debt / EBITDA

0.1x

FY 2025

EV / EBITDA

-0.2x

Employees

—